Bionano Genomics, Inc. (BNGO) Current Ratio
- Current ratio · latest quarter: Value 2.48×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 2.48× | Current assets / current liabilities. $24.88M ÷ $10.04M ≈ 2.48× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 24.88M USD | Assets, Current |
| Current obligations | 10.04M USD | Liabilities, Current |
| Cash and equivalents | 3.73M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 6.19M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 4.37M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 7.01M USD | Inventory, Net |
| Payables | 4.56M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $24.88M | $10.04M | $3.73M | $6.19M | $4.37M | $7.01M | $4.56M | (m) | 2.48× |
| 2026-03-31 | $38.98M | $21.23M | $3.42M | $10.98M | $4.13M | $7.69M | $5.06M | (m) | 1.84× |
| 2025-12-31 | $45.39M | $22.94M | $2.99M | $16.28M | $5.20M | $7.83M | $5.59M | (m) | 1.98× |
| 2025-09-30 | $48.80M | $22.98M | $3.06M | $18.52M | $4.53M | $8.42M | $5.99M | (m) | 2.12× |
| 2025-06-30 | $42.66M | $24.18M | $3.56M | $12.88M | $3.49M | $10.31M | $6.24M | (m) | 1.76× |
| 2025-03-31 | $44.93M | $26.41M | $3.63M | $14.61M | $3.35M | $11.42M | $6.56M | (m) | 1.70× |
| 2024-12-31 | $39.49M | $37.34M | $9.17M | $302.00K | $4.75M | $13.28M | $6.96M | (m) | 1.06× |
| 2024-09-30 | $46.98M | $32.95M | $8.79M | $3.16M | $5.32M | $16.28M | $8.70M | (m) | 1.43× |
| 2024-06-30 | $60.57M | $37.17M | $10.43M | $8.52M | $6.25M | $23.15M | $8.73M | (m) | 1.63× |
| 2024-03-31 | $85.61M | $58.51M | $15.76M | $12.56M | $8.31M | $23.80M | $9.84M | (m) | 1.46× |
| 2023-12-31 | $140.12M | $100.03M | $17.95M | $48.82M | $9.32M | $27.60M | $10.38M | (m) | 1.40× |
| 2023-09-30 | $104.54M | $40.19M | $34.57M | $29.01M | $8.67M | $33.51M | $15.37M | (m) | 2.60× |
| 2023-06-30 | $122.58M | $33.50M | $14.86M | $62.21M | $7.61M | $32.45M | $11.91M | (m) | 3.66× |
| 2023-03-31 | $142.56M | $38.13M | $4.10M | $91.70M | $6.78M | $33.11M | $15.78M | (m) | 3.74× |
| 2022-12-31 | $157.30M | $35.88M | $5.09M | $108.09M | $7.02M | $29.76M | $12.53M | (m) | 4.38× |
| 2022-09-30 | $218.20M | $33.50M | $28.17M | $152.02M | $5.83M | $25.05M | $9.41M | (m) | 6.51× |
| 2022-06-30 | $216.29M | $27.91M | $27.16M | $160.18M | $4.85M | $20.59M | $7.70M | (m) | 7.75× |
| 2022-03-31 | $242.36M | $18.66M | $24.05M | $192.42M | $5.51M | $16.27M | $6.59M | (m) | 12.99× |
| 2021-12-31 | $272.41M | $21.84M | $24.57M | $226.04M | $4.93M | $12.39M | $10.77M | (m) | 12.47× |
| 2021-09-30 | $342.05M | $17.70M | $140.74M | $185.33M | $3.00M | $9.02M | $7.88M | (m) | 19.32× |
| 2021-06-30 | $341.96M | $10.73M | $332.55M | (m) | $2.84M | $4.89M | $3.75M | (m) | 31.87× |
| 2021-03-31 | $370.25M | $7.17M | $362.06M | (m) | $1.99M | $3.04M | $2.21M | (m) | 51.65× |
| 2020-12-31 | $46.79M | $8.95M | $38.45M | $0.00 | $2.77M | $3.31M | $2.93M | (m) | 5.23× |
| 2020-09-30 | $29.24M | $24.78M | $18.87M | (m) | $3.86M | $4.59M | $5.67M | $14.24M | 1.18× |
| 2020-06-30 | $24.65M | $19.51M | $17.19M | (m) | $3.25M | $3.29M | $2.85M | $13.94M | 1.26× |
| 2020-03-31 | $16.98M | $23.19M | $8.14M | (m) | $4.12M | $3.61M | $3.18M | $16.97M | 0.73× |
| 2019-12-31 | $28.26M | $26.37M | $17.31M | (m) | $6.33M | $3.44M | $2.70M | $20.08M | 1.07× |
| 2019-09-30 | $17.84M | $7.44M | $8.22M | (m) | $6.00M | $2.60M | $2.63M | (m) | 2.40× |
| 2019-06-30 | $23.93M | $7.54M | $15.29M | (m) | $4.98M | $3.02M | $3.62M | (m) | 3.17× |
| 2019-03-31 | $28.01M | $4.71M | $20.83M | (m) | $4.06M | $1.41M | $870.84K | (m) | 5.94× |
| 2018-12-31 | $23.03M | $4.52M | $16.52M | (m) | $4.51M | $1.07M | $1.35M | $0.00 | 5.09× |
| 2018-09-30 | $28.62M | $5.51M | $20.66M | (m) | $4.00M | $2.61M | $2.36M | $0.00 | 5.19× |
| 2017-12-31 | $7.14M | $16.65M | $1.02M | (m) | $3.35M | $1.69M | $2.30M | $6.73M | 0.43× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |